Works matching IS 03407004 AND DT 2021 AND VI 70 AND IP 3
Results: 25
PD-1/PD-L1 checkpoint inhibitors in combination with olaparib display antitumor activity in ovarian cancer patient-derived three-dimensional spheroid cultures.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 843, doi. 10.1007/s00262-021-02849-z
- By:
- Publication type:
- Article
High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 831, doi. 10.1007/s00262-020-02769-4
- By:
- Publication type:
- Article
Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b study.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 857, doi. 10.1007/s00262-020-02738-x
- By:
- Publication type:
- Article
Pembrolizumab and atezolizumab in triple-negative breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 607, doi. 10.1007/s00262-020-02736-z
- By:
- Publication type:
- Article
Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 619, doi. 10.1007/s00262-020-02735-0
- By:
- Publication type:
- Article
Systematic analysis of immune-related genes based on a combination of multiple databases to build a diagnostic and a prognostic risk model for hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 773, doi. 10.1007/s00262-020-02733-2
- By:
- Publication type:
- Article
Downregulated ATP6V1B1 expression acidifies the intracellular environment of cancer cells leading to resistance to antibody-dependent cellular cytotoxicity.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 817, doi. 10.1007/s00262-020-02732-3
- By:
- Publication type:
- Article
Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 763, doi. 10.1007/s00262-020-02730-5
- By:
- Publication type:
- Article
Anti-leukemia effect associated with down-regulated CD47 and up-regulated calreticulin by stimulated macrophages in co-culture.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 787, doi. 10.1007/s00262-020-02728-z
- By:
- Publication type:
- Article
Differential gene expression of tumor-infiltrating CD33+ myeloid cells in advanced- versus early-stage colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 803, doi. 10.1007/s00262-020-02727-0
- By:
- Publication type:
- Article
A systematic scoping review on natural killer cell function in colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 597, doi. 10.1007/s00262-020-02721-6
- By:
- Publication type:
- Article
A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC).
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 743, doi. 10.1007/s00262-020-02720-7
- By:
- Publication type:
- Article
Flow cytometric analysis of circulating endothelial cells and endothelial progenitor cells in pediatric solid tumors: prognostic impact on treatment response and survival.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 755, doi. 10.1007/s00262-020-02719-0
- By:
- Publication type:
- Article
Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 701, doi. 10.1007/s00262-020-02718-1
- By:
- Publication type:
- Article
Varied functions of immune checkpoints during cancer metastasis.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 569, doi. 10.1007/s00262-020-02717-2
- By:
- Publication type:
- Article
Monophosphoryl lipid A-induced activation of plasmacytoid dendritic cells enhances the anti-cancer effects of anti-PD-L1 antibodies.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 689, doi. 10.1007/s00262-020-02715-4
- By:
- Publication type:
- Article
Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 589, doi. 10.1007/s00262-020-02714-5
- By:
- Publication type:
- Article
Next-generation humanized patient-derived xenograft mouse model for pre-clinical antibody studies in neuroblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 721, doi. 10.1007/s00262-020-02713-6
- By:
- Publication type:
- Article
Increased thyroid uptake on 18F-FDG PET/CT is associated with the development of permanent hypothyroidism in stage IV melanoma patients treated with anti-PD-1 antibodies.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 679, doi. 10.1007/s00262-020-02712-7
- By:
- Publication type:
- Article
Unique TP53 neoantigen and the immune microenvironment in long-term survivors of Hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 667, doi. 10.1007/s00262-020-02711-8
- By:
- Publication type:
- Article
Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 657, doi. 10.1007/s00262-020-02709-2
- By:
- Publication type:
- Article
Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 869, doi. 10.1007/s00262-020-02708-3
- By:
- Publication type:
- Article
Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 713, doi. 10.1007/s00262-020-02706-5
- By:
- Publication type:
- Article
Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm study.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 733, doi. 10.1007/s00262-020-02704-7
- By:
- Publication type:
- Article
Anti-tumor and immune modulating activity of T cell induced tumor-targeting effectors (TITE).
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 633, doi. 10.1007/s00262-020-02692-8
- By:
- Publication type:
- Article